Westover Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Sell |
2,004
-6
| -0.3% | -$4.68K | 0.31% | 70 |
|
|
2025
Q1 | $1.66M | Sell |
2,010
-110
| -5% | -$90.9K | 0.37% | 61 |
|
|
2024
Q4 | $1.64M | Sell |
2,120
-2
| -0.1% | -$1.54K | 0.36% | 65 |
|
|
2024
Q3 | $1.88M | Buy |
2,122
+179
| +9% | +$159K | 0.36% | 59 |
|
|
2024
Q2 | $1.76M | Buy |
1,943
+27
| +1% | +$24.4K | 0.45% | 56 |
|
|
2024
Q1 | $1.49M | Hold |
1,916
| – | – | 0.44% | 60 |
|
|
2023
Q4 | $1.12M | Sell |
1,916
-344
| -15% | -$201K | 0.36% | 71 |
|
|
2023
Q3 | $1.21M | Hold |
2,260
| – | – | 0.44% | 54 |
|
|
2023
Q2 | $1.06M | Sell |
2,260
-1
| -0% | -$469 | 0.37% | 67 |
|
|
2023
Q1 | $776K | Buy |
2,261
+2
| +0.1% | +$687 | 0.29% | 80 |
|
|
2022
Q4 | $826K | Sell |
2,259
-47
| -2% | -$17.2K | 0.33% | 74 |
|
|
2022
Q3 | $746K | Hold |
2,306
| – | – | 0.29% | 79 |
|
|
2022
Q2 | $748K | Hold |
2,306
| – | – | 0.28% | 78 |
|
|
2022
Q1 | $660K | Hold |
2,306
| – | – | 0.21% | 92 |
|
|
2021
Q4 | $637K | Hold |
2,306
| – | – | 0.19% | 97 |
|
|
2021
Q3 | $533K | Hold |
2,306
| – | – | 0.17% | 98 |
|
|
2021
Q2 | $529K | Sell |
2,306
-6
| -0.3% | -$1.38K | 0.17% | 100 |
|
|
2021
Q1 | $432K | Sell |
2,312
-40
| -2% | -$7.47K | 0.15% | 109 |
|
|
2020
Q4 | $397K | Buy |
2,352
+200
| +9% | +$33.8K | 0.14% | 104 |
|
|
2020
Q3 | $319K | Hold |
2,152
| – | – | 0.13% | 104 |
|
|
2020
Q2 | $353K | Buy |
2,152
+467
| +28% | +$76.6K | 0.17% | 90 |
|
|
2020
Q1 | $234K | Hold |
1,685
| – | – | 0.13% | 104 |
|
|
2019
Q4 | $221K | Buy |
+1,685
| New | +$221K | 0.1% | 130 |
|
|
2019
Q2 | – | Sell |
-1,685
| Closed | -$219K | – | 146 |
|
|
2019
Q1 | $219K | Buy |
+1,685
| New | +$219K | 0.11% | 126 |
|